Država: Australija
Jezik: engleski
Izvor: Department of Health (Therapeutic Goods Administration)
lidocaine, Quantity: 20 mg/mL; chlorhexidine gluconate, Quantity: 0.5 mg/mL
Pfizer Australia Pty Ltd
Gel
Excipient Ingredients: glacial acetic acid; water for injections; sodium hydroxide; propylene glycol; hyetellose; acetic acid
Urethral
10 x 10 mL
Medicine Registered
(S2) Pharmacy Medicine
For local anaesthesia and lubrication of the urethra prior to catheterization. Cystoscopy and symptomatic treatment of painful cystisis and urethritis.
Visual Identification: Clear colourless gel; Container Type: Syringe; Container Material: PP; Container Life Time: 18 Months; Container Temperature: Store below 25 degrees Celsius
Registered
1991-07-09
Version: pfpligcg11020 Supersedes: pfpligcg10316 Page 1 of 10 AUSTRALIAN PRODUCT INFORMATION – LIGNOCAINE 2% GEL WITH CHLORHEXIDINE 0.05% [LIDOCAINE (LIGNOCAINE) AND CHLORHEXIDINE GLUCONATE] 1. NAME OF THE MEDICINE Lidocaine (lignocaine) and chlorhexidine gluconate. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Lignocaine 2% Gel with Chlorhexidine 0.05% is a sterile, colourless, water-soluble gel containing lidocaine (lignocaine) 20 mg/mL, chlorhexidine gluconate 500 micrograms/mL, propylene glycol, hyetellose, glacial acetic acid, sodium hydroxide and acetic acid (for pH adjustment) and water for injections. For the full list of excipients, see Section 6.1 List of excipients. 3. PHARMACEUTICAL FORM Clear colourless gel. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Local anaesthesia and lubrication during catheterisation, exploration by sound and other endourethral operations and examinations. Cystoscopy and symptomatic treatment of painful cystitis and urethritis. 4.2 DOSE AND METHOD OF ADMINISTRATION When lignocaine is used for surface anaesthesia it should be remembered that it may be rapidly absorbed via the mucous membranes and systemic effects may occur. Reactions and complications are best avoided by employing the minimum effective dosage. Debilitated or elderly patients and children should be given doses relative to their age and physical condition. The dose of topical lignocaine should be taken into consideration in estimating the total dose of lignocaine if parenteral lignocaine is to be administered concomitantly. The following dosage recommendations should be regarded as a guide. The clinician's experience and knowledge of the patient's physical status are of importance in calculating the required dose. Version: pfpligcg11020 Supersedes: pfpligcg10316 Page 2 of 10 MALES The usual dose required for adequate analgesia is 20 mL (equiv. lignocaine 400 mg). The gel is instilled slowly into the urethra until it reaches the external sphincter, proximal to the prostate, where a certain resistance is fe Pročitajte cijeli dokument